S 2364 · 118th Congress 2023–2025, ended

MAPS Act

Latest action · Jul 18, 2023 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJul 18, 2023
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Mapping America's Pharmaceutical Supply Act or the MAPS Act

This bill requires the Department of Health and Human Services (HHS) to support efforts to map the U.S. pharmaceutical supply chain and identify associated vulnerabilities.

As part of these efforts, HHS must support the development of a database of certain essential medicines and the identification of information about their supply chain, including the location of manufacturing facilities. Qualifying essential medicines are those that are likely to be needed in the event of a public health emergency or chemical, biological, radiological, or nuclear threat or for which a shortage would pose a significant threat to the U.S. health care system or at-risk populations. 

Cosponsors 2

Members who signed on, in the order they did. All signed on Jul 18, 2023.

SeatCosponsorSigned on
R-OKJames LankfordOriginalJul 18, 2023
R-INMike BraunOriginalJul 18, 2023

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateHealth, Education, Labor, and Pensions Committee
Referred Jul 18, 2023

Actions 2

Everything that happened, newest first.

  1. Jul 18, 2023Introduced in Senate
  2. Jul 18, 2023Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
S. Hrg. 118-750DRUG SHORTAGES: EXAMINING SUPPLY CHALLENGES, IMPACTS, AND POLICY SOLUTIONS FROM A FEDERAL HEALTH PROGRAM PERSPECTIVE157 pagesFinance CommitteeDec 5, 2023

Titles 3

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to map the United States pharmaceutical supply chain and use data analytics to identify supply chain vulnerabilities and other national security threats.
Short Title(s) as Introduced
MAPS Act
Mapping America's Pharmaceutical Supply Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Jul 18, 2023Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.